Literature DB >> 11157745

Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein.

C Wong1, L W Xiong, M Horiuchi, L Raymond, K Wehrly, B Chesebro, B Caughey.   

Abstract

A conformational conversion of the normal, protease- sensitive prion protein (PrP-sen or PrP(C)) to a protease-resistant form (PrP-res or PrP(Sc)) is commonly thought to be required in transmissible spongiform encephalopathies (TSEs). Endogenous sulfated glycosaminoglycans are associated with PrP-res deposits in vivo, suggesting that they may facilitate PrP-res formation. On the other hand, certain exogenous sulfated glycans can profoundly inhibit PrP-res accumulation and serve as prophylactic anti-TSE compounds in vivo. To investigate the seemingly paradoxical effects of sulfated glycans on PrP-res formation, we have assayed their direct effects on PrP conversion under physiologically compatible cell-free conditions. Heparan sulfate and pentosan polysulfate stimulated PrP-res formation. Conversion was stimulated further by increased temperature. Both elevated temperature and pentosan polysulfate promoted interspecies PrP conversion. Circular dichroism spectropolarimetry measurements showed that pentosan polysulfate induced a conformational change in PrP-sen that may potentiate its PrP-res-induced conversion. These results show that certain sulfated glycosaminoglycans can directly affect the PrP conversion reaction. Therefore, depending upon the circumstances, sulfated glycans may be either cofactors or inhibitors of this apparently pathogenic process.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11157745      PMCID: PMC133469          DOI: 10.1093/emboj/20.3.377

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  55 in total

1.  Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.

Authors:  M Horiuchi; B Caughey
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

2.  pH-dependent stability and conformation of the recombinant human prion protein PrP(90-231).

Authors:  W Swietnicki; R Petersen; P Gambetti; W K Surewicz
Journal:  J Biol Chem       Date:  1997-10-31       Impact factor: 5.157

3.  Eight prion strains have PrP(Sc) molecules with different conformations.

Authors:  J Safar; H Wille; V Itri; D Groth; H Serban; M Torchia; F E Cohen; S B Prusiner
Journal:  Nat Med       Date:  1998-10       Impact factor: 53.440

4.  Chaperone-supervised conversion of prion protein to its protease-resistant form.

Authors:  S K DebBurman; G J Raymond; B Caughey; S Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

5.  BSE and prions: uncertainties about the agent.

Authors:  B Chesebro
Journal:  Science       Date:  1998-01-02       Impact factor: 47.728

6.  Scrapie infectivity found in resistant species.

Authors:  R Race; B Chesebro
Journal:  Nature       Date:  1998-04-23       Impact factor: 49.962

7.  NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231).

Authors:  R Riek; S Hornemann; G Wider; R Glockshuber; K Wüthrich
Journal:  FEBS Lett       Date:  1997-08-18       Impact factor: 4.124

8.  Characterization and polyanion-binding properties of purified recombinant prion protein.

Authors:  D B Brimacombe; A D Bennett; F S Wusteman; A C Gill; J C Dann; C J Bostock
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

9.  Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible.

Authors:  D G Donne; J H Viles; D Groth; I Mehlhorn; T L James; F E Cohen; S B Prusiner; P E Wright; H J Dyson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

10.  Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells.

Authors:  B Caughey; G J Raymond
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

View more
  82 in total

1.  Strains of [PSI(+)] are distinguished by their efficiencies of prion-mediated conformational conversion.

Authors:  S M Uptain; G J Sawicki; B Caughey; S Lindquist
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

Review 2.  Allosteric function and dysfunction of the prion protein.

Authors:  Rafael Linden; Yraima Cordeiro; Luis Mauricio T R Lima
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

3.  Plasminogen: A cellular protein cofactor for PrPSc propagation.

Authors:  Charles E Mays; Chongsuk Ryou
Journal:  Prion       Date:  2011-01-01       Impact factor: 3.931

Review 4.  Structural requirements for efficient prion protein conversion: cofactors may promote a conversion-competent structure for PrP(C).

Authors:  Andrew C Gill; Sonya Agarwal; Teresa J T Pinheiro; James F Graham
Journal:  Prion       Date:  2010-10-20       Impact factor: 3.931

Review 5.  Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions.

Authors:  Byron Caughey; Gerald S Baron; Bruce Chesebro; Martin Jeffrey
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

6.  Lipopolysaccharide induced conversion of recombinant prion protein.

Authors:  Fozia Saleem; Trent C Bjorndahl; Carol L Ladner; Rolando Perez-Pineiro; Burim N Ametaj; David S Wishart
Journal:  Prion       Date:  2014-05-12       Impact factor: 3.931

7.  In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate.

Authors:  Bonto Faburay; Dongseob Tark; Anumantha G Kanthasamy; Juergen A Richt
Journal:  Prion       Date:  2014       Impact factor: 3.931

8.  Ligand binding promotes prion protein aggregation--role of the octapeptide repeats.

Authors:  Shuiliang Yu; Shaoman Yin; Nancy Pham; Poki Wong; Shin-Chung Kang; Robert B Petersen; Chaoyang Li; Man-Sun Sy
Journal:  FEBS J       Date:  2008-11       Impact factor: 5.542

9.  Prion propagation and toxicity occur in vitro with two-phase kinetics specific to strain and neuronal type.

Authors:  Samia Hannaoui; Layal Maatouk; Nicolas Privat; Etienne Levavasseur; Baptiste A Faucheux; Stéphane Haïk
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

10.  Prion protein glycosylation is not required for strain-specific neurotropism.

Authors:  Justin R Piro; Brent T Harris; Koren Nishina; Claudio Soto; Rodrigo Morales; Judy R Rees; Surachai Supattapone
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.